including fetal anemia and hypoxia. This condition arises from genetic mutations that affect the production of hemoglobin, the protein in red blood cells responsible for carrying oxygen.

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the company will encore data from the BEACON Phase 1/2 ...

Can we predict that natural selection will weed out genetic disease over time ... correlates with differences in the mean levels of fetal hemoglobin (FH) in patients with different haplotypes.

leading to increased production of non-sickling and anti-sickling fetal hemoglobin (HbF) and thus mimicking the effects of naturally occurring variants seen in hereditary persistence of fetal ...

leading to increased production of non-sickling and anti-sickling fetal hemoglobin (HbF) and thus mimicking the effects of naturally occurring variants seen in hereditary persistence of fetal ...